| DLK in complex with inhibitor 2-((1-cyclopentyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-3-yl)a… | | monomer | 117-398 | 1×50F; |
| Assess |
| CRYSTAL STRUCTURE OF DLK IN COMPLEX WITH COMPOUND 22 | | monomer | 118-399 | 1×W3C; |
| Assess |
| DLK in complex with inhibitor N-(1-isopropyl-5-(piperidin-4-yl)-1H-pyrazol-3-yl)-4-(trifluoromethyl… | | monomer | 117-398 | 1×50E; |
| Assess |
| DLK in complex with inhibitor 2-((6-(3,3-difluoropyrrolidin-1-yl)-4-(1-(oxetan-3-yl)piperidin-4-yl)… | | monomer | 117-398 | 1×50D; |
| Assess |
| DLK in complex with compound 10 (5-(1-isopropyl-5-(3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1… | | monomer | 117-398 | 1×9FS; |
| Assess |
| Crystal structure of DLK in complex with inhibitor DN0011197 | | monomer | 117-398 | 1×SIQ; |
| Assess |
| DLK in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-3-yl)-3-(… | | monomer | 117-398 | 1×9FV; |
| Assess |
| Crystal structure of DLK (kinase domain) | | monomer | 117-397 | |
| Assess |
| CRYSTAL STRUCTURE OF DLK IN COMPLEX WITH COMPOUND 19 | | monomer | 118-397 | 1×W3I; |
| Assess |
| CRYSTAL STRUCTURE OF DLK IN COMPLEX WITH COMPOUND 16 | | monomer | 118-396 | 1×W38; |
| Assess |